help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-1575
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Dissen, G. A.
Right arrow Articles by Ojeda, S. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dissen, G. A.
Right arrow Articles by Ojeda, S. R.
Endocrinology Vol. 150, No. 6 2906-2914
Copyright © 2009 by The Endocrine Society

Excessive Ovarian Production of Nerve Growth Factor Facilitates Development of Cystic Ovarian Morphology in Mice and Is a Feature of Polycystic Ovarian Syndrome in Humans

Gregory A. Dissen, Cecilia Garcia-Rudaz, Alfonso Paredes, Christine Mayer, Artur Mayerhofer and Sergio R. Ojeda

Division of Neuroscience (G.A.D., C.G.-R., S.R.O.), Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon 97006-3448; Laboratory of Neurobiochemistry (A.P.), Department of Biochemistry and Molecular Biology, Facultad of Chemistry and Pharmaceutical Sciences, Universidad De Chile, 1 Santiago 6640750, Chile; and Institute for Cell Biology (C.M., A.M.), University of Munich, D-80802 Munich, Germany

Address all correspondence and requests for reprints to: Gregory A. Dissen or Sergio R. Ojeda, Division of Neuroscience, Oregon National Primate Research Center, 505 Northwest 185th Avenue, Beaverton, Oregon 97006-3448. E-mail: disseng{at}ohsu.edu and ojedas{at}ohsu.edu.

Although ovarian nerve growth factor (NGF) facilitates follicular development and ovulation, an excess of the neurotrophin in the rodent ovary reduces ovulatory capacity and causes development of precystic follicles. Here we show that ovarian NGF production is enhanced in patients with polycystic ovarian syndrome (PCOS) and that transgenically driven overproduction of NGF targeted to the ovary results in cystic morphology, when accompanied by elevated LH levels. NGF levels are increased in the follicular fluid from PCOS ovaries and in the culture medium of granulosa cells from PCOS patients, as compared with non-PCOS patients. Ovaries from transgenic mice carrying the NGF gene targeted to thecal-interstitial cells by the 17{alpha}-hydroxylase gene promoter produce more NGF than wild-type (WT) ovaries and are hyperinnervated by sympathetic nerves. Antral follicle growth is arrested resulting in accumulation of intermediate size follicles, many of which are apoptotic. Peripubertal transgenic mice respond to a gonadotropin challenge with a greater increase in plasma 17-hydroxyprogesterone, estradiol, and testosterone levels than WT controls. Transgenic mice also exhibit a reduced ovulatory response, delayed puberty, and reduced fertility, as assessed by a prolonged interval between litters, and a reduced number of pups per litter. Sustained, but mild, elevation of plasma LH levels results in a heightened incidence of ovarian follicular cysts in transgenic mice as compared with WT controls. These results suggest that overproduction of ovarian NGF is a component of polycystic ovarian morphology in both humans and rodents and that a persistent elevation in plasma LH levels is required for the morphological abnormalities to appear.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. Julio-Pieper, P. Lozada, V. Tapia, M. Vega, C. Miranda, D. Vantman, S. R. Ojeda, and C. Romero
Nerve Growth Factor Induces Vascular Endothelial Growth Factor Expression in Granulosa Cells via a trkA Receptor/Mitogen-Activated Protein Kinase-Extracellularly Regulated Kinase 2-Dependent Pathway
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3065 - 3071.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society